Normal view MARC view ISBD view

Non-destructive Determination of Shikimic Acid Concentration in Transgenic Maize Exhibiting Glyphosate Tolerance Using Chlorophyll Fluorescence and Hyperspectral Imaging. [electronic resource]

By:

Feng, Xuping

Contributor(s):

Publication details: Frontiers in plant science 2018Description: 468 p. digitalISSN:

1664-462X

Online resources:

Available from publisher's website

In: Frontiers in plant science vol. 9

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

No physical items for this record

Publication Type: Journal Article

There are no comments on this title.

to post a comment.

Back to results

1 Complex trauma, impact on development and possible solutions on an adolescent intensive care unit.
by Jonsson, Pall Vidalin
2 Global topological features of cancer proteins in the human interactome.
by Jonsson, Pall F
3 Variations in primary care prescribing: lessons to be learnt for GP commissioners.
by Houten, Rachel
4 DECISION-COMPONENTS OF NICE'S TECHNOLOGY APPRAISALS ASSESSMENT FRAMEWORK.
by de Folter, Joost
5 Key enablers and barriers to implementing adaptive pathways in the European setting.
by Rejon-Parrilla, Juan Carlos
6 Structural context of exons in protein domains: implications for protein modelling and design.
by Contreras-Moreira, Bruno
7 NICE guidance on inhaled mannitol for treatment of cystic fibrosis.
by Jennings, Grace
8 Cluster analysis of networks generated through homology: automatic identification of important protein communities involved in cancer metastasis.
by Jonsson, Pall F
9 Using HTA and guideline development as a tool for research priority setting the NICE way: reducing research waste by identifying the right research to fund.
by Sharma, Tarang
10 How should we assess the clinical and cost effectiveness of histology independent cancer drugs?
by Cooper, Sophie
11 Reweighting Randomized Controlled Trial Evidence to Better Reflect Real Life - A Case Study of the Innovative Medicines Initiative.
by Happich, Michael
12 Using Real-World Data in Health Technology Assessment (HTA) Practice: A Comparative Study of Five HTA Agencies.
by Makady, Amr
13 Alignment of European Regulatory and Health Technology Assessments: A Review of Licensed Products for Alzheimer's Disease.
by Dekker, Marieke J H J
14 Transparent Reporting on Research Using Unstructured Electronic Health Record Data to Generate 'Real World' Evidence of Comparative Effectiveness and Safety.
by Wang, Shirley V
15 Practical implications of using real-world evidence (RWE) in comparative effectiveness research: learnings from IMI-GetReal.
by Makady, Amr
16 Regulatory and Health Technology Assessment Considerations for Disease-Modifying Drugs in Alzheimer's Disease.
by Bouvy, Jacoline C
17 Machine learning and artificial intelligence research for patient benefit: 20 critical questions on transparency, replicability, ethics, and effectiveness.
by Vollmer, Sebastian
18 Challenges for Optimizing Real-World Evidence in Alzheimer's Disease: The ROADMAP Project.
by Gallacher, John